These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2081717)

  • 1. A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae.
    Piddock LJ; Traynor EA; Wise R
    J Antimicrob Chemother; 1990 Dec; 26(6):749-62. PubMed ID: 2081717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria.
    Piddock LJ; Traynor EA
    J Antimicrob Chemother; 1991 Aug; 28(2):209-19. PubMed ID: 1778852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection and characterization of cefepime-resistant gram-negative bacteria.
    Piddock LJ; Griggs DJ
    J Antimicrob Chemother; 1991 Nov; 28(5):669-76. PubMed ID: 1778870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of FCE 22101-resistant Enterobacteriaceae and the effect of FCE 22101 upon the activity of anti-pseudomonal beta-lactams for Pseudomonas aeruginosa.
    Piddock LJ; Traynor EA
    J Antimicrob Chemother; 1991 Sep; 28(3):369-75. PubMed ID: 1960118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.
    Dupont H; Gaillot O; Goetgheluck AS; Plassart C; Emond JP; Lecuru M; Gaillard N; Derdouri S; Lemaire B; Girard de Courtilles M; Cattoir V; Mammeri H
    Antimicrob Agents Chemother; 2016 Jan; 60(1):215-21. PubMed ID: 26482307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in-vitro activity and beta-lactamase stability of carumonam.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1986 Jul; 18(1):35-44. PubMed ID: 3531143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?
    Marshall S; Hujer AM; Rojas LJ; Papp-Wallace KM; Humphries RM; Spellberg B; Hujer KM; Marshall EK; Rudin SD; Perez F; Wilson BM; Wasserman RB; Chikowski L; Paterson DL; Vila AJ; van Duin D; Kreiswirth BN; Chambers HF; Fowler VG; Jacobs MR; Pulse ME; Weiss WJ; Bonomo RA
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sch 34343 activity against streptococci and beta-lactam-resistant Enterobacteriaceae.
    Gutmann L; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():147-54. PubMed ID: 3897168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.
    Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR
    Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity and beta-lactamase stability of a new monobactam, B0-1165.
    Neu HC; Chin NX
    Antimicrob Agents Chemother; 1987 Apr; 31(4):505-11. PubMed ID: 3300528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cefotaxime or ceftazidime susceptibility tests for predicting susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa.
    Heym B; Lacroix O; Péan Y; Gertner J; Nicolas MH; Jarlier V
    J Antimicrob Chemother; 1994 Apr; 33(4):729-35. PubMed ID: 8056691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam.
    Gutmann L; Kitzis MD; Billot-Klein D; Goldstein F; Tran Van Nhieu G; Lu T; Carlet J; Collatz E; Williamson R
    Rev Infect Dis; 1988; 10(4):860-6. PubMed ID: 3055178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
    Martínez-Beltrán J; Calderón C; Sierra MP; Alvarez M; Cantón R
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
    Jarlier V; Nicolas MH; Philippon A; Giroir AM; Grosset J
    J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
    Piddock LJ; Hall MC; Walters RN
    J Antimicrob Chemother; 1991 Aug; 28(2):185-98. PubMed ID: 1663926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae.
    Bush K; Tanaka SK; Bonner DP; Sykes RB
    Antimicrob Agents Chemother; 1985 Apr; 27(4):555-60. PubMed ID: 3873900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.
    Livermore DM; Oakton KJ; Carter MW; Warner M
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2831-7. PubMed ID: 11557477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the in vitro activity of ceftazidime/avibactam and aztreonam among carbapenemase-producing Enterobacteriaceae: Defining the zone of hope.
    Avery LM; Nicolau DP
    Int J Antimicrob Agents; 2018 Nov; 52(5):688-691. PubMed ID: 30044946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.